300119SZSE

Ringpu 2025 Environmental, Social, and Governance (ESG) Report

Tianjin Ringpu Bio-technology Co., Ltd.··61 pages

✨ AI Summary

This report details Ringpu Bio's 2025 ESG performance, focusing on governance, environmental impact, and social responsibility. Key initiatives include strengthening ESG governance, optimizing environmental management, and promoting social contributions. The company achieved significant milestones in product innovation, market expansion, and corporate social responsibility, demonstrating a commitment to sustainable development and stakeholder value.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

2025 Environmental, Social, and Governance (ESG) Report

Report Description

The "Environmental, Social, and Governance (ESG) Report 2025" (hereinafter referred to as "this Report") is the fourth ESG report released by Ringpu Bio Co., Ltd. and its subsidiaries (hereinafter referred to as "Ringpu Bio," "the Company," or "we"). This Report presents the Company's practices and performance in the economic, environmental, social, and governance fields with the principles of objectivity, standardization, transparency, and comprehensiveness, to stakeholders.

Report Scope

The information disclosed in this Report covers Ringpu Bio and its subsidiaries, consistent with the scope of Ringpu Bio's consolidated financial statements. Please refer to the "Ringpu Bio Co., Ltd. 2025 Annual Report" for details.

Time Period

This Report is an annual report covering the period from January 1, 2025, to December 31, 2025. To enhance comparability and completeness, some content extends beyond this period.

Basis of Preparation

This Report is prepared in accordance with the "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 2 — Norms for the Operation of GEM Companies (2025 Revision)," "Shenzhen Stock Exchange GEM Company Self-Regulatory Supervision Guide No. 3 — Sustainable Development Report Preparation," the "China Enterprise Sustainable Development Report Guide (CASS-ESG 6.0)" by the China Enterprise Reform and Development Research Society, the "Global Reporting Initiative (GRI) Standards," and the United Nations Sustainable Development Goals (SDGs), among other mainstream domestic and international standards.

Data Sources and Reliability Assurance

The information and data disclosed in this Report are derived from Ringpu Bio's internal official documents, statistical reports, and annual reports. Where data disclosed in this Report differs from that in Ringpu Bio's 2025 Annual Report, the Annual Report shall prevail. This Report was reviewed and approved by the Board of Directors on March 27, 2026.

Currency

Unless otherwise specified, all amounts in this Report are presented in RMB.

Forward-Looking Statements Disclaimer

Forward-looking statements in this Report, involving future plans, do not constitute substantive commitments by the Company to investors. Investors and related parties should maintain sufficient risk awareness and understand the difference between plans, forecasts, and commitments.

Report Acquisition

This Report is available in electronic format on the Company's website (https://www.ringpu.com/) and the Shenzhen Stock Exchange website (https://www.szse.cn/index/index.html) in simplified Chinese.

Glossary

TermDefinition
Shareholders' MeetingShareholders' Meeting of Ringpu Bio Co., Ltd.
Board of DirectorsBoard of Directors of Ringpu Bio Co., Ltd.
Ringpu TianjinRingpu (Tianjin) Pharmaceutical Co., Ltd.
Airport Branch CompanyRingpu Bio Technology Co., Ltd. Tianjin Airport Economic Area Branch Company
Ringpu GaokeRingpu Gaoke (Tianjin) Biotechnology Co., Ltd.
Ringpu BaodingRingpu (Baoding) Pharmaceutical Co., Ltd.
Bohai Animal HusbandryBohai Animal Husbandry Industry Joint Research Institute Co., Ltd.
Inner Mongolia Ringpu AgricultureInner Mongolia Ringpu Agriculture Technology Co., Ltd.
Xinjiang Ringpu Epidemic Prevention and ControlXinjiang Ringpu Animal Epidemic Prevention and Control Services Co., Ltd.
Aowei An TaiInner Mongolia Aowei An Tai Biotechnology Co., Ltd.
Longxiang PharmaceuticalHubei Longxiang Pharmaceutical Technology Co., Ltd.
South China BioGuangzhou South China Agricultural University Animal Biological Products Co., Ltd.
Shanxi Ringxiang BioShanxi Ringxiang Pharmaceutical Co., Ltd.
Ringpu DadiInner Mongolia Ringpu Dadi Pharmaceutical Co., Ltd.
Zhongrui Supply ChainTianjin Zhongrui Supply Chain Management Co., Ltd.
Ringpai Pet HospitalRingpai Pet Hospital Management Co., Ltd.
Ruibao FundTianjin Ruibao Equity Investment Partnership (Limited Partnership)

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.